Invesco Nasdaq Biotechnology ETF Performance

IBBQ ETF

USD 29.50 0.07 0.24%

Invesco Nasdaq's price-return history is consolidated with risk-adjusted measures like Sharpe and alpha. The stock's expected return across the 3 months window is 0.0434%.

Risk-Adjusted Performance

Soft

0100

Invesco Nasdaq Biotechnology currently ranks below 2% of comparable global equities and portfolios when recent risk-adjusted returns are measured across a 90-day horizon. Return quality should be judged alongside the volatility required to produce it. Invesco Nasdaq has produced near-zero returns recently, indicating neutral to weak return quality for holders. Learn More

Relative Risk vs. Return Landscape

If you had invested $ 2,882 in Invesco Nasdaq Biotechnology on February 5, 2026 and sold it today, you would have earned $ 61.00 , a return of 2.12% over 90 days. Invesco Nasdaq Biotechnology is currently generating a 0.0434% daily expected return and carries 1.4% risk (volatility on return distribution) over a 90-day horizon. In relative terms, Invesco Nasdaq exhibits above-average volatility, exceeding roughly 88% of comparable etfs, and IBBQ has trailed 99% of traded instruments in return over the 90-day horizon.

Expected Return

Risk

This relative risk-return summary evaluates how the instrument behaves against its benchmark. It is intended to show how efficiently risk has translated into return over the selected horizon. Given a 90-day horizon, IBBQ generates 1.45 times more return on investment than the market. However, IBBQ is 1.45 times more volatile than its market benchmark. Its risk-adjusted efficiency stands at about 0.03% per unit of risk. Dow Jones Industrial is currently generating roughly 0.02% per unit of risk.

Target Price Odds to finish over Current Price

One of the most enduring patterns in ETF markets is the tendency for prices to revert toward averages. This mean-reverting tendency has been a useful forecasting tool, though some ETFs exhibit persistent mispricings. The speed of convergence varies because some ETFs carry risk factors not immediately reflected in price.

Current Price	Horizon	Target Price	Odds moving above the current price in 90 days
29.50	90 days	29.50	about 34.24 %

Applying a normal distribution to this ETF, the odds of Invesco Nasdaq moving above the current price in 90 days from now are about 34.24 %. Based on past return behavior, the distribution of outcomes has been weighted above current levels over this period. (The probability curve shows the outcome range with the heaviest concentration for Invesco Nasdaq ETF over 90 days). A tighter center suggests recent price behavior has been clustering into a narrower range for Invesco Nasdaq ETF.

Given a 90-day horizon, the ETF has the beta coefficient of 1.06 . This usually indicates Invesco Nasdaq Biotechnology market returns are sensible to returns on the market. As the market goes up or down, Invesco Nasdaq tends to follow. Additionally, Invesco Nasdaq Biotechnology has an alpha of 0.0124, implying that it can generate a 0.0124 percent excess return over Dow Jones Industrial after adjusting for the inherent market risk (beta).

Invesco Nasdaq Price Density

Price

Predictive Modules for Invesco Nasdaq

For Invesco Nasdaq, multiple forecasting techniques provide different perspectives on future ETF price direction. No method can consistently predict the ETF market with certainty, but disciplined forecasting sharpens analysis. Comparing the outputs of diverse models helps set realistic expectations for Invesco Nasdaq price behavior.

Mean reversion analysis in Invesco Nasdaq's involves identifying price extremes that diverge materially from the historical norm. High prices relative to historical norms contrast with unusually low prices, where recovery expectations may emerge. Mean reversion in Invesco Nasdaq is distinct from trend following, which rides momentum rather than betting on reversals.

Sentiment

Range

Low	Sentiment	High
28.10	29.50	30.90

Details

Intrinsic

Valuation

Low	Intrinsic	High
27.98	29.38	30.78

Details

Naive

Forecast

Low	Next	High
27.19	28.59	29.99

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
28.47	29.50	30.52

Details

Invesco Nasdaq's financial and valuation profile is evaluated here relative to direct competitors. Invesco Nasdaq's multiples and operating metrics gain context when measured against direct competitors. Growth rates, profitability, and capital efficiency relative to peers frame Invesco Nasdaq's competitive position.

Primary Risk Indicators

The ETF market's volatility over the past 10-20 years has tested even experienced investors in Invesco Nasdaq. Large corrections and rapid recoveries have created challenges for investors in Invesco Nasdaq Biotechnology. A disciplined approach to monitoring Invesco Nasdaq's risk indicators supports more effective hedging decisions.

α	Alpha over Dow Jones	0.01	Details
β	Beta against Dow Jones	1.06	Details
σ	Overall volatility	0.69	Details
Ir	Information ratio	0.01	Details

Invesco Nasdaq Fundamentals Growth

Invesco Nasdaq's financial fundamentals are the foundation of Invesco Nasdaq ETF market pricing and valuation. Metrics like earnings growth, revenue consistency, and margin trends collectively determine market sentiment toward Invesco Nasdaq ETF. Invesco Nasdaq ETF market pricing reflects the collective assessment of Invesco Nasdaq's financial fundamentals.

Performance Metrics & Calculation Methodology

Invesco Nasdaq risk-adjusted performance compares returns to the volatility absorbed while tracking its benchmark. Sharpe and Sortino ratios frame return efficiency relative to total and downside risk.

Invesco Nasdaq Biotechnology analytics rely on fund disclosures and market reference feeds, with quality checks and normalization applied. Return and risk statistics are calculated from historical price series.

Editorial review and methodology oversight provided by: Vlad Skutelnik, Macroaxis Contributor